LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker

There is a pressing need to identify prognostic markers of metastatic disease and targets for treatment. Combining high-throughput RNA sequencing, functional characterization, mechanistic studies and clinical validation, we identify leukemia inhibitory factor receptor (LIFR) as a breast cancer metas...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chen, Dahu, Sun, Yutong, Wei, Yongkun, Zhang, Peijing, Rezaeian, Abdol Hossein, Teruya-Feldstein, Julie, Gupta, Sumeet, Liang, Han, Lin, Hui-Kuan, Hung, Mien-Chie, Ma, Li
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3684419/
https://ncbi.nlm.nih.gov/pubmed/23001183
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nm.2940
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados